salicylic acid has been researched along with acetyl coenzyme a in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lee, IS; Lim, HW; Maksimoska, J; Man, N; Marmorstein, R; Meier, J; Newman, JC; Nimer, S; Ott, M; Schröder, S; Shimazu, T; Shirakawa, K; Sorum, AW; Verdin, E; Wang, L | 1 |
1 other study(ies) available for salicylic acid and acetyl coenzyme a
Article | Year |
---|---|
Salicylate, diflunisal and their metabolites inhibit CBP/p300 and exhibit anticancer activity.
Topics: Acetyl Coenzyme A; Acetylation; Animals; Antineoplastic Agents; Binding, Competitive; Catalytic Domain; Cell Line, Tumor; Core Binding Factor Alpha 2 Subunit; Diflunisal; Enzyme Inhibitors; Gene Expression Regulation, Leukemic; HEK293 Cells; Humans; Leukemia, Myeloid, Acute; Leukocytes; Mice; Mice, SCID; Oncogene Proteins, Fusion; p300-CBP Transcription Factors; Protein Binding; RUNX1 Translocation Partner 1 Protein; Salicylic Acid; Signal Transduction; Structure-Activity Relationship; Xenograft Model Antitumor Assays | 2016 |